Literature DB >> 15232723

Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.

Suleyman R Cayli1, Ayhan Kocak, Ugur Yilmaz, Ayhan Tekiner, Mine Erbil, Cetin Ozturk, Kadir Batcioglu, Saim Yologlu.   

Abstract

Spinal cord injury (SCI) results in the loss of function below the lesion. Secondary injury following the primary impact includes a number of biochemical and cellular alterations leading to tissue necrosis and cell death. Methylprednisolone (MP), by reducing edema and protecting the cell membrane against peroxidation, is the only pharmacological agent with a proven clinically beneficial effect on SCI. Melatonin, known as a free radical scavenger, has been shown to have an effect on lipid peroxidation following experimental SCI. The purpose of this study was to examine the effect of MP and melatonin on neurological, ultrastructural, and electrophysiological recovery. Female albino rats weighing 200-250 g were randomized into five groups of 18 rats each and six rats for the control group. Weight-drop trauma was performed for each group and a 30-mg/kg single dose of MP for rats in group 1, a 10-mg/kg single dose of melatonin for rats in group 2, and MP and melatonin in the same doses for rats in group 3 were administered immediately after trauma. The rats in group 4 were the vehicle group (treated with ethanol) and group 5 was the trauma group. The motor and somatosensory evoked potentials were recorded at the 4th hour, the 24th hour, and on the 10th day of the study for six rats in each group. Posttraumatic neurological recovery was recorded for 10 days using "motor function score" and inclined plane test. After electrophysiological study the rats were terminated for an analysis of lipid peroxidation level of the injured site of the spinal cord. Electron microscopic studies were performed to determine the effects of melatonin, MP, and the combined treatment with MP and melatonin on axons, neurons, myelin, nucleus, and intracytoplasmic edema. The groups treated with MP, melatonin, and a combination of both had significantly enhanced electrophysiological, biochemical, and neurological recovery and also showed better ultrastructural findings than the trauma and vehicle groups. Although combined treatment was significantly more effective on lipid peroxidation than melatonin or MP treatments alone, at the 10th day, neurobehavioral, electrophysiological, and ultrastructural recovery were at the same level. In conclusion, MP, melatonin, and MP and melatonin combined treatment modalities improved functional recovery at the same level. Future studies involving different doses of melatonin and different dose combinations with MP could promise better results since each drug has a different anti-oxidative mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232723      PMCID: PMC3454055          DOI: 10.1007/s00586-003-0550-y

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  26 in total

1.  Objective clinical assessment of motor function after experimental spinal cord injury in the rat.

Authors:  A S Rivlin; C H Tator
Journal:  J Neurosurg       Date:  1977-10       Impact factor: 5.115

2.  Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury.

Authors:  E Kaptanoglu; H H Caner; H S Sürücü; F Akbiyik
Journal:  J Neurosurg       Date:  1999-10       Impact factor: 5.115

Review 3.  A review and update of experiment and clinical studies of spinal cord injury.

Authors:  W F Collins
Journal:  Paraplegia       Date:  1983-08

4.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

Authors:  M Mihara; M Uchiyama
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

5.  Potent protective effects of melatonin on experimental spinal cord injury.

Authors:  T Fujimoto; T Nakamura; T Ikeda; K Takagi
Journal:  Spine (Phila Pa 1976)       Date:  2000-04-01       Impact factor: 3.468

6.  Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis.

Authors:  E D Hall; D L Wolf; J M Braughler
Journal:  J Neurosurg       Date:  1984-07       Impact factor: 5.115

7.  Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism.

Authors:  J M Braughler; E D Hall
Journal:  J Neurosurg       Date:  1984-08       Impact factor: 5.115

8.  Correlation of methylprednisolone levels in cat spinal cord with its effects on (Na+ + K+)-ATPase, lipid peroxidation, and alpha motor neuron function.

Authors:  J M Braughler; E D Hall
Journal:  J Neurosurg       Date:  1982-06       Impact factor: 5.115

9.  Experimental spinal cord trauma, I: Correlation of blood flow, tissue oxygen and neurologic status in the dog.

Authors:  T B Ducker; M Salcman; P L Perot; D Ballantine
Journal:  Surg Neurol       Date:  1978-07

10.  Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury.

Authors:  W Young; E S Flamm
Journal:  J Neurosurg       Date:  1982-11       Impact factor: 5.115

View more
  19 in total

1.  Systematic review of melatonin levels in individuals with complete cervical spinal cord injury.

Authors:  Alexander Whelan; Mary Halpine; Sean D Christie; Sonja A McVeigh
Journal:  J Spinal Cord Med       Date:  2018-08-22       Impact factor: 1.985

2.  The evaluation of different treatment protocols for trauma-induced lung injury in rats.

Authors:  Hızır Ufuk Akdemir; Aygül Güzel; Celal Katı; Latif Duran; Hasan Alaçam; Ayhan Gacar; Tolga Güvenç; Naci Murat; Bülent Sişman
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

3.  The effects of 4-aminopyridine and methylprednisolone on recovery of the facial nerve crush injury.

Authors:  Murat Toraman; Semra Külekçi Öztürk; Berna Uslu Coşkun; Pembegül Güneş
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-11-23       Impact factor: 2.503

4.  Protective effect of ginkgolide B against acute spinal cord injury in rats and its correlation with the Jak/STAT signaling pathway.

Authors:  Yongxing Song; Zhongyou Zeng; Caiyi Jin; Jianqiao Zhang; Baoyue Ding; Feng Zhang
Journal:  Neurochem Res       Date:  2012-12-29       Impact factor: 3.996

5.  Evaluation of the neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury.

Authors:  Amit D Kandhare; V Shivakumar; Anuchandra Rajmane; Pinaki Ghosh; Subhash L Bodhankar
Journal:  J Nat Med       Date:  2014-05-01       Impact factor: 2.343

6.  Effects of Melatonin and Dexamethasone on Facial Nerve Neurorrhaphy.

Authors:  Deniz Tuna Edizer; Zehra Dönmez; Mehmet Gül; Özgür Yiğit; Birgül Yiğitcan; Turgut Adatepe; Nurten Uzun
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

Review 7.  Melatonin as an anti-inflammatory agent in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; A H Rezaeyan; A Salajegheh; S Rezapoor
Journal:  Inflammopharmacology       Date:  2017-03-02       Impact factor: 4.473

8.  Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

Authors:  Alfredo Gorio; Laura Madaschi; Barbara Di Stefano; Stephana Carelli; Anna Maria Di Giulio; Silvia De Biasi; Thomas Coleman; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

9.  Decreased GFAP expression and improved functional recovery in contused spinal cord of rats following valproic acid therapy.

Authors:  Marzieh Darvishi; Taki Tiraihi; Seyed A Mesbah-Namin; AliReza Delshad; Taher Taheri
Journal:  Neurochem Res       Date:  2014-09-10       Impact factor: 3.996

10.  Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats.

Authors:  Supriti Samantaray; Eric A Sribnick; Arabinda Das; Varduhi H Knaryan; D Denise Matzelle; Anil V Yallapragada; Russel J Reiter; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2007-12-13       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.